Back to search

Article

Tumor-Informed ddPCR for Personalized Longitudinal ctDNA Monitoring: Molecular–Radiological Concordance and Molecular Lead Time

2026-08-27

Abstract excerpt

<h4>Background: </h4> Radiological assessment of treatment response in advanced solid tumors is episodic and may delay recognition of biological progression. We evaluated personalized tumor-informed circulating tumor DNA (ctDNA) monitoring using droplet digital PCR (ddPCR) to determine its association with radiological response and tumor burden, characterize longitudinal molecular–radiological concordance, quantif...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f2d00e90-5226-5a7a-8b3c-6205e3e1959b
DOI
10.20944/preprints202608.1950.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor-Informed ddPCR for Personalized Longitudinal ctDNA Monitoring: Molecular–Radiological Concordance and Molecular Lead TimeDOI 10.20944/preprints202608.1950.v1
Clinical and Radiometabolic Correlatives of ddPCR Liquid Biopsy for BRAF V600 Mutated Melanoma.Semantic proximity
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study.Semantic proximity
A Novel Cell-Free DNA Fragmentomics Assay and Its Application for Monitoring Disease Progression in Real-Time for Stage IV Cancer PatientsSemantic proximity
Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept studySemantic proximity
Multimodal ctDNA profiling for cancer detection and monitoring in pan-cancer patients with advanced disease enrolled in the SHIVA02 trialSemantic proximity
Rational thresholding of circulating tumor DNA concentration for improved surveillance of metastatic breast cancerSemantic proximity
The implementation of liquid biopsies in routine care of patients with advanced solid cancer (LIQPLAT): a study protocol for a single arm trialSemantic proximity
Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors.Semantic proximity
Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA Profiling.Semantic proximity
Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer StudySemantic proximity
Early Assessment of Molecular Progression and Response by Whole-genome Circulating Tumor DNA in Advanced Solid Tumors.Semantic proximity
Longitudinal Relationship between Idylla Plasma ctBRAF V600 Mutation Detection and Tumor Burden in Patients with Metastatic Melanoma.Semantic proximity
Select a neighboring publication to make it the new centre.